TREATMENT WITH IL2/VACCINIA RECOMBINANT VIRUS LEADS TO SEROLOGIC, HISTOLOGIC AND PHENOTYPIC NORMALIZATION OF AUTOIMMUNE MRL/LPR-LPR MICE

被引:15
作者
GUTIERREZRAMOS, JC
ANDREU, JL
MARCOS, MAR
VEGAZO, IR
MARTINEZ, C
机构
[1] Centro de Biologia Molecular (CSIC-UAM), Universidad Autonoma de Madrid, Madrid, Campus de Cantoblanco
[2] Institute Pasteur, Paris, Cedex
[3] Clinica Puerta de Hierro, 28035, Madrid
[4] Basel Institute for Immunology, Basel
关键词
LYMPHOKINES; VIRUS VECTOR DELIVERY SYSTEM; T-CELLS; AUTOIMMUNE DISEASE;
D O I
10.3109/08916939108997143
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have analyzed the effect of IL2 administered in vivo on both the lymphoproliferation and autoimmune disease progression of MRL/lpr mice. Human IL2 was delivered by infecting MRL/lpr mice with vaccinia virus recombinants at different stages of lpr disease. The results reported here showed that treatment of lpr mice with IL2 mediated: (I) restored normal thymic differentiation illustrated by an expansion of the double positive population accompanied by increased numbers of mature thymocytes; (2) depletion of the peripheral CD3+CD4+CD8-(DN) T-cell population, which is abnormally expanded in lpr mice, and a consequent restoration of the normal mature T cell population; (3) normalization in the pattern of TcRVβ gene expression displayed by mature T cells; (4) decreased urine-protein levels and immune complex deposition in the kidney, with a resultant absence of glomerulonephritis; and (5) an increased longevity (from 195 to more than 400 days). We speculate that the dramatic reduction in the abnormally expanded CD3+DN T-cell population following IL2 therapy might be directly related to the amelioration and/or prevention of autoimmune disease in these mice. Collectively, these results suggest that diseases showing a selective expansion of DN cells should be envisaged as possible targets for the treatment described here. © 1991 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:15 / 25
页数:11
相关论文
共 46 条
[1]  
Theophilopoulos A., Dixon F.J., Murine models of SLE, Adv Immunol, 37, pp. 269-390, (1988)
[2]  
Katagiri T., Cohen P.L., Eisenberg R.A., The lpr gene causes an intrinsic T-cell abnormality that is required for hyperproliferation, J Exp Med, 167, 7, pp. 41-751, (1988)
[3]  
Izui S., Kelley V.E., Masuda K., Yoshida H., Roths J.B., Murphy E.D., Induction of various autoantibodies by mutant lpr gene in several strains of mice, J Immunol, 133, pp. 227-335, (1984)
[4]  
Theophilopoulos A.N., Balderas R.S., Shawler D.L., Lee S., Dixon F.J., Influence of thymic genotype on the systemic lupus erythematous-like disease and T-cell proliferation of MRL/lpr mice, J Exp Med, 153, pp. 1405-1414, (1981)
[5]  
Prud'homme G.J., Park C.L., Fieser T.M., Kofler R., Dixon F.J., Theophilopoulos A.N., Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T-cells in murine lupus strains of the lpr/lpr genotype, J Exp Med, 157, pp. 730-742, (1983)
[6]  
Davignon J.L., Budd R.C., Ceredig R., Piguet P.F., MacDonald H.R., Cerottini J.C., Vasalli P., Izui S., Functional analysis of T-cell subsets from mice bearing the lpr gene, J Immunol, 135, pp. 2423-2428, (1985)
[7]  
Roths J.B., Izui S., Kellen V.E., Murphy E.D., Modification of expression of lpr by background genome, Fed Proc, 42, pp. 1075-1079, (1983)
[8]  
Altman A., Theophilopoulos A.N., Weiner R., Katz D.H., Dixon F.J., Analysis of T-cell function in autoimmune murine strains. Defects in production of and responsiveness to IL-2, J Exp Med, 154, pp. 783-791, (1981)
[9]  
Wofsy D., Murphy E.D., Roths J.B., Dauphinee M.J., Kipper S.B., Talal N., Deficient 1L-2 activity in MRL and in CS7DRb16 mice bearing the lpr gene, J Exp Med, 154, pp. 1671-1680, (1981)
[10]  
Weston K.M., Ju S.-T., Lu C.Y., Sy M.-S., Autoreactive T cells in MRL/lpr mice. Characterization of the lymphokines produced and analysis of antigen presenting cells required, J Immunol, 141, pp. 1941-1948, (1988)